Author

Farees Kamal

Institutions: Interactive Research and Development, Institut de Recherche pour le Développement

Observed institutions: Interactive Research and Development, Institut de Recherche pour le Développement

OpenAlex ID: A5143377057

Bedaquiline, Delamanid, Linezolid and Clofazimine for the Treatment of Rifampicin- and Fluoroquinolone-Resistant Tuberculosis (endTB-Q): A Phase 3, Open-Label, Multicentre, Randomised, Controlled, Stratified, Non-Inferiority Trial

2025 · Lorenzo Guglielmetti, Uzma Khan, et al. · SSRN Electronic Journal · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: